Keros Therapeutics, Inc. — SCHEDULE 13D/A Filings
7 SCHEDULE 13D/A filings on record
This page lists all SCHEDULE 13D/A filings submitted to the SEC by Keros Therapeutics, Inc. (KROS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Keros Therapeutics, Inc. has filed 7 SCHEDULE 13D/A documents with the SEC since 2016. To view all SEC filings by Keros Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS EX
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0000921895-25-002751 | Oct 16, 2025 | — |
| SCHEDULE 13D/A | — | 0000902664-25-004410 | Oct 15, 2025 | — |
| SCHEDULE 13D/A | — | 0000902664-25-003804 | Aug 21, 2025 | — |
| SCHEDULE 13D/A | — | 0000902664-25-002254 | May 12, 2025 | — |
| SCHEDULE 13D/A | — | 0000902664-25-002179 | May 8, 2025 | — |
| SCHEDULE 13D/A | — | 0001104659-25-040354 | Apr 28, 2025 | — |
| SCHEDULE 13D/A | — | 0001999371-25-004429 | Apr 18, 2025 | — |